COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly

Código QR

COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly

Pursuing vaccinations against COVID-19 brings hope to limit the spread of SARS-CoV-2 and remains the most rational decision under pandemic conditions. However, it does not come without challenges, including temporary shortages in vaccine doses, significant vaccine inequity, and questions regarding t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, Robert Flisiak, Willis Gwenzi, Roya Kelishadi, Alexander Leemans, Juan J. Nieto, Ahmet Ozen, Matjaž Perc, Barbara Poniedziałek, Constantine Sedikides, Frank Sellke, Emilia C. Skirmuntt, Anzhela Stashchak, Nima Rezaei
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	immunology pandemic massive vaccinations vaccine inequity SARS-CoV-2 Medicine R
Acceso en línea:	https://doaj.org/article/79582b985a6c45618e72bb00b70b05e2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
por: Piotr Rzymski, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 vaccines: The good, the bad, and the ugly
por: Katia N. Estrada-Medrano, et al.
Publicado: (2021)

A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination
por: Bettina Experton, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy and Attitude toward Booster Doses among US Healthcare Workers
por: Suman Pal, et al.
Publicado: (2021)

Vaccine
Publicado: (1983)

Possible HSP reactivation post‐COVID‐19 vaccination and booster
por: Makoto Kondo, et al.
Publicado: (2021)

Inmunogenicidad y reactogenicidad de una vacuna de difteria, tétanos, pertussis acelular de contenido antigénico reducido (dTpa) en niños de 10 a 11 años de edad y en adultos
por: Abarca V,Katia, et al.
Publicado: (2002)

The Good, the Bad, and the Ugly: Food Packaging and Consumers
por: Sophie Langley, et al.
Publicado: (2021)

Vaccine: X
Publicado: (2019)

Travelers’ vaccines and their adverse events in Nara, Japan
por: Ogawa Taku, et al.
Publicado: (2021)

Influenza Vaccination Programs for Healthcare Personnel: Organizational Issues and Beyond
por: Helena C. Maltezou, et al.
Publicado: (2021)

Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections
por: Paul Loubet, et al.
Publicado: (2021)

Factors Associated with Attitudes towards Seasonal Influenza Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2020
por: Piotr Samel-Kowalik, et al.
Publicado: (2021)

Vaccinating against COVID-19: The Correlation between Pro-Vaccination Attitudes and the Belief That Our Peers Want to Get Vaccinated
por: Darie Cristea, et al.
Publicado: (2021)

Evaluacion de la capacidad inmunogénica de la vacuna antirrábica tipo Fuenzalida- Palacios (CRL) y de la vacuna antirrábica de cultivo celular (Verorab®) en personas con tratamiento preexposición
por: Favi C,Myriam, et al.
Publicado: (2004)

Caregivers’ Willingness to Vaccinate Their Children against Childhood Diseases and Human Papillomavirus: A Cross-Sectional Study on Vaccine Hesitancy in Malawi
por: Gbadebo Collins Adeyanju, et al.
Publicado: (2021)

COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers
por: Khalid Alhasan, et al.
Publicado: (2021)

HIV Env-Specific IgG Antibodies Induced by Vaccination of Neonatal Rhesus Macaques Persist and Can Be Augmented by a Late Booster Immunization in Infancy
por: Alan D. Curtis, et al.
Publicado: (2020)

The Barriers, Challenges, and Strategies of COVID-19 (SARS-CoV-2) Vaccine Acceptance: A Concurrent Mixed-Method Study in Tehran City, Iran
por: Hamid Reza Khankeh, et al.
Publicado: (2021)

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China
por: Liubing Gong, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses
por: Martin C. S. Wong, et al.
Publicado: (2021)

Estimating Vaccine Confidence Levels among Healthcare Staff and Students of a Tertiary Institution in South Africa
por: Elizabeth O. Oduwole, et al.
Publicado: (2021)

Vaccine Knowledge, Awareness and Hesitancy: A Cross Sectional Survey among Parents Residing at Sandakan District, Sabah
por: James Yau Hon Voo, et al.
Publicado: (2021)

Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
por: Madison Crutcher, et al.
Publicado: (2021)

A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly
por: Hsu PS, et al.
Publicado: (2020)

Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
por: Serge Goldman, et al.
Publicado: (2021)

COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis
por: Clio Bilotta, et al.
Publicado: (2021)

LIVE ATTENUATED VACCINES FOR THE IMMUNOPROPHYLAXIS
por: O. A. Shamsutdinova
Publicado: (2017)

Pneumonia immunization in older adults: review of vaccine effectiveness and strategies
por: Assaad U, et al.
Publicado: (2012)

Acceptance of the COVID-19 Vaccine by Foreigners in South Korea
por: Chiara Achangwa, et al.
Publicado: (2021)

Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
por: Li-Meng Yan, et al.
Publicado: (2020)

Fake news and fallacies: Exploring vaccine hesitancy in South Africa
por: Avania Bangalee, et al.
Publicado: (2021)

Immunomodulatory Strategies for Parapoxvirus: Current Status and Future Approaches for the Development of Vaccines against Orf Virus Infection
por: Alhaji Modu Bukar, et al.
Publicado: (2021)

Inmunogenicidad de una vacuna recombinante anti hepatitis B en personal de salud
por: GARCÍA C.,PATRICIA, et al.
Publicado: (2002)

Surveying children and adult vaccination program against diphtheria, tetanus, measles and viral hepatitis B in the Russian Federation
por: N. P. Galina, et al.
Publicado: (2020)

Prevalence and Factors Associated with Parents’ Non-Intention to Vaccinate Their Children and Adolescents against COVID-19 in Latin America and the Caribbean
por: Diego Urrunaga-Pastor, et al.
Publicado: (2021)

COVID-19 Vaccine Acceptance among Liver Transplant Recipients
por: Andrea Costantino, et al.
Publicado: (2021)

Evaluation of the Efficacy of the <named-content content-type="genus-species">Brucella canis</named-content> RM6/66 Δ<italic toggle="yes">vjbR</italic> Vaccine Candidate for Protection against <named-content content-type="genus-species">B. canis</named-content> Infection in Mice
por: Lauren W. Stranahan, et al.
Publicado: (2020)

Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study on a Mexican Population Using an Online Questionnaire (COV-AHQ)
por: Juan Luis Delgado-Gallegos, et al.
Publicado: (2021)

COVID-19 Vaccine Hesitancy in Healthcare Personnel: A University Hospital Experience
por: Beril Kara Esen, et al.
Publicado: (2021)